Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Equity (Parenthetical)

v3.22.0.1
Consolidated Statements of Equity (Parenthetical) - shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Shares outstanding (in shares) 112,327,533 112,181,759 112,068,705 110,241,868
Conversion of common units to common shares (in shares) 8,054 14,009 105,039  
Share-based compensation issuance, net of redemptions (in shares) 137,720 99,045 106,711  
Common Stock At-the-Market Program        
Common shares issued during the period (in shares)     1,000  
Forward Equity Sale Agreement        
Common shares issued during the period (in shares)     1,614,087